111, Inc. Sponsored ADR

YI Healthcare Medical Distribution

111, Inc. Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $1.8 billion, down 9.00% from fiscal 2024. In the quarter to March 2026, revenue fell 29.6%, EPS fell 200.0%, free cash flow fell 185.7% and total debt rose 82.5%, each against the same quarter a year earlier.

3.09 0.00 0.00%
Market cap
$16.0M
P/E
0.0×
Fwd P/E
0.0×
Dividend yield
—
F-score
5/9
Altman Z
3.31
Beneish M
−3.28
Dividend safety
n/a
Mar '26 Dec '25 Sep '25 Jun '25 Older periods
Piotroski F-Score
4 5 5 7

+8 more TTM periods

ROE
12.26% 9.82% 10.10% 11.19%
ROA
(3.89%) (2.73%) (2.45%) (2.80%)
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
(52.06%) (34.53%) (36.78%) (24.98%)
Average Days of Receivables
6.05 7.55 7.78 6.94
Free Cash Flow per Share
(1.34) 1.02 0.48 1.78
Free Cash Flow
(11.78) 8.84 4.17 15.42
Capital Expenditures
— (8.20) — —
Other line items
Cash ROIC
77.70% 79.76% 127.92% (1,355.36%)
Accounts Receivable Turnover
51.50 38.31 37.06 41.58
Accounts Payable Turnover
7.64 8.07 7.15 8.42
Inventory Turnover
9.37 10.17 8.88 10.03
Average Days of Payables
41.22 39.56 45.38 43.09
Days of Inventory on Hand
34.55 30.80 36.71 35.43
Tax Rate
0.00 0.00 0.00 0.00
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
2.74% 2.61% 2.53% 2.52%
Share Based Compensation of Revenue
0.00% 3.32% 0.00% 0.00%
Interest Coverage
(0.65) (0.07) (0.32) (0.16)
Operating CF/Net income
0.95 (1.79) (0.44) (1.51)
Depreciation/Fixed assets
0.00 4.31 0.00 0.00
Capex/Depreciation
— (0.63) — —
Revenue per Share
187.78 206.35 212.99 224.33
Operating CF per Share
(1.34) 1.96 0.48 1.78
Capex per Share
0.00 (0.94) 0.00 0.00
Capex to Sales
0.00 0.00 0.00 0.00

Fold the line items

Columns are period end dates